Concepedia

CR Valiathan

CV

1

Publications

117

Citations

1

H-Index

2016

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

CR Valiathan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, tumor biology, and cancer research.

Top concepts

Publications per year

2016–2016

1

Publications

1

Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose-Range Selection of the Anti-PD-1 Antibody Pembrolizumab

Andreas Lindauer, CR Valiathan, Khamir Mehta et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 117 citations · Full text

, , +20

Rows per page

1–1 of 1